Component information
Different name of ingredient
- Belantamabum mafodotinum
- Belantamab mafodotine
- Belantamab mafodotina
- Immunoglobulin G1-kappa, anti-[Homo sapiens TNFRSF17 (TNF receptor superfamily member 17, tumor necrosis factor receptor superfamily, member 17, B cell maturation antigen, BCMA, BCM, TNFRSF13A, CD269)], humanized monoclonal antibody conjugated to auristatin F; gamma1 heavy chain (1-451) [humanized VH (Homo sapiens IGHV1-69*06 (83.7%)-(IGHD)-IGHJ4*01 (85.7%))[8.8.14] (1-121)-Homo sapiens IGHG1*01, G1m17,1 (CH1 K120 (218) (122-219), hinge (220-234), CH2 (235-344), CH3 D12 (360), L14 (362) (345-449
- GSK 2857916 (GlaxoSmithKline)
- Belantamab mafodotin
Alternative medicine with selected ingredient
| Name | PZN | Form | Packing | Manufacturer | Price | |
|---|---|---|---|---|---|---|
| Details | BLENREP 100 mg Plv.f.e.Konz.z.Herst.e.Inf.-Lsg. | P19454347 | PKI | 100 mg | GSK | € 7196.13 |
| Details | BLENREP 70 mg Plv.f.e.Konz.z.Herst.e.Inf.-Lsg. | P19454353 | PKI | 70 mg | GSK | € 5054.58 |